A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT06375512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: HZ Vaccine (IN001)
BIOLOGICAL: Placebo
BIOLOGICAL: Shingrix

Sponsor

Shenzhen Shenxin Biotechnology Co., Ltd